According to the report, in the current post-crisis period of financial reform there is an unprecedented level of scrutiny and requirements for firms to show procedural consistency with a need for disclosure and valuation methodologies as key starting points for restoring confidence in structured finance markets.
The report states that âFINCAD has continued to strengthen its analytics across multiple asset classes and now has enhanced capabilities to support cross-asset pricing for structured products. FINCAD particularly stands out not only in terms of having a broad asset class coverage for its pricing libraries, but also significant ISV partners that embed its models and tools in their applications, therefore enabling clients to gain more consistent access to its models in third party applications.â
âIn todayâs evolving market, significant changes are underway due to market volatility, threats to liquidity, counterparty and operational risks, and regulatory pressures. Market participants are now required to re-examine approaches to measuring and mitigating their risks,â said Bob Park, president and CEO, FINCAD. âThe results of the Celent report are further affirmation of FINCADâs commitment to providing our clients with a comprehensive derivative valuation solution that meet their needs for transparency, risk measurement, independent valuation and regulatory compliance.â
The report, Pricing Solutions for OTC Derivatives and Structured Products â Evaluating the Vendor Market, examines eight vendors that deliver pricing solutions that can strengthen an organizationâs efforts for reform. The report is available to Celent subscribers.